Neuroscience News and Research

RSS

Preterm infants with slower growth have delayed development in the cerebral cortex

Preterm infants who grow more slowly as they approached what would have been their due dates also have slower development in an area of the brain called the cerebral cortex, report Canadian researchers in a new study published today in Science Translational Medicine.

17 Jan 2013

Athletes with concussions in early adulthood may be at increased risk of depression as they age

National Football League (NFL) players may be at increased risk of depression as they age due to brain damage resulting from concussions, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

Jersey Shore University Medical Center launches Meridian Executive Health program

Jersey Shore University Medical Center announces the launch of the Meridian Executive Health program, a health care pilot initiative designed for busy individuals whose schedule demands a streamlined but high quality experience.

17 Jan 2013

Women who have migraine with aura more likely to develop major cardiovascular events

Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

Study: Social stigma of chronic migraine and epilepsy are similar

A groundbreaking study lead by William B. Young, MD, a neurologist at Thomas Jefferson University Hospital's Headache Center, shows that patients with migraine (a combination of severe headache, nausea, light sensitivity, and other factors) suffer social stigma from their disease similar to the stigma experienced by patients with epilepsy.

17 Jan 2013

Some epileptic seizures may originate in glia: Study

Epileptic seizures occur when neurons in the brain become excessively active. However, a new study from MIT neuroscientists suggests that some seizures may originate in non-neuronal cells known as glia, which were long believed to play a mere supporting role in brain function.

17 Jan 2013

Report describes 2 brain underpinnings of emotion dysregulation in borderline personality disorder

Originally, the label "borderline personality disorder" was applied to patients who were thought to represent a middle ground between patients with neurotic and psychotic disorders. Increasingly, though, this area of research has focused on the heightened emotional reactivity observed in patients carrying this diagnosis, as well as the high rates with which they also meet diagnostic criteria for posttraumatic stress disorder and mood disorders.

17 Jan 2013

Fifteen established scientists to receive NARSAD Distinguished Investigator Grants

The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) announced the latest recipients of its highly competitive NARSAD Distinguished Investigator Grants.

16 Jan 2013

Stroke survivors with depression more likely to die

People who are depressed after a stroke may have a tripled risk of dying early and four times the risk of death from stroke than people who have not experienced a stroke or depression, according to a study that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

16 Jan 2013

Elan, Biogen Idec submit applications to FDA and EMA for updation of TYSABRI labels

Today Biogen Idec and Elan Corporation, plc announced that they have submitted applications to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) requesting updates to the TYSABRI (natalizumab) labels.

16 Jan 2013

People with early Parkinson's frequently experience many non-motor symptoms

While movement problems are the main symptom of Parkinson's disease, a new study shows that even early in the course of disease people frequently experience many non-motor symptoms such as drooling, anxiety and constipation.

16 Jan 2013

Vanderbilt University, AstraZeneca partner to identify candidate drugs for major brain diseases

Today, AstraZeneca and Vanderbilt University announced they have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer's disease and schizophrenia.

16 Jan 2013

Patients with Parkinson's develop artistic talents after dopamine-inducing therapy

Parkinson's experts across the world have been reporting a remarkable phenomenon - many patients treated with drugs to increase the activity of dopamine in the brain as a therapy for motor symptoms such as tremors and muscle rigidity are developing new creative talents, including painting, sculpting, writing, and more.

16 Jan 2013

Study explains how Timothy syndrome mutation causes wiring defects that underlie cognition

A new finding in neuroscience for the first time points to a developmental mechanism linking the disease-causing mutation in an autism-related disorder, Timothy syndrome, and observed defects in brain wiring, according to a study led by scientist Ricardo Dolmetsch and published online yesterday in Nature Neuroscience.

16 Jan 2013

Off-label drug ineffective in frontotemporal dementia

A randomized, controlled trial has dashed hopes that memantine therapy could benefit patients with frontotemporal dementia.

14 Jan 2013

Cancer researchers solve mystery of how Chd5 protein exerts its beneficial effects

A team of cancer researchers at Cold Spring Harbor Laboratory (CSHL) has solved the mystery of how one of the most powerful of the body's natural tumor-suppressing proteins, called Chd5, exerts its beneficial effects.

11 Jan 2013

Results from Morphotek’s farletuzumab Phase III combination study on ovarian cancer

Morphotek Inc., a wholly-owned subsidiary of Eisai Inc., announced today top-line results from a Phase III study of its investigational agent farletuzumab (MORAb-003) in combination with carboplatin and a taxane in patients with platinum-sensitive epithelial ovarian cancer in first relapse.

11 Jan 2013

Neuroscience News and Research

Preterm infants with slower growth have delayed development in the cerebral cortex

Athletes with concussions in early adulthood may be at increased risk of depression as they age

Jersey Shore University Medical Center launches Meridian Executive Health program

Women who have migraine with aura more likely to develop major cardiovascular events

Study: Social stigma of chronic migraine and epilepsy are similar

Some epileptic seizures may originate in glia: Study

Report describes 2 brain underpinnings of emotion dysregulation in borderline personality disorder

Fifteen established scientists to receive NARSAD Distinguished Investigator Grants

Stroke survivors with depression more likely to die

Elan, Biogen Idec submit applications to FDA and EMA for updation of TYSABRI labels

People with early Parkinson's frequently experience many non-motor symptoms

Vanderbilt University, AstraZeneca partner to identify candidate drugs for major brain diseases

Patients with Parkinson's develop artistic talents after dopamine-inducing therapy

Study explains how Timothy syndrome mutation causes wiring defects that underlie cognition

Off-label drug ineffective in frontotemporal dementia

Cancer researchers solve mystery of how Chd5 protein exerts its beneficial effects

Results from Morphotek’s farletuzumab Phase III combination study on ovarian cancer

Saliva gland test shows promise for Parkinson's

Apparent stem cell transplant success in mice may hold promise for people with ALS

LM11A-31 effective at improving limb movement after spinal cord injury in mice

Neuroscience - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News